COPD Clinical Trials

Showing 1241-1260 of 1,730 trials

Well Being and Rehabilitation in Chronically Ill Patients: Structured Patient Education and Physical Exercise

NCT00989456

This study addresses self management and maintenance of health through evaluation of a program of patient education in combination with physical training and with a structured follow-up. It is hypothesized that such a program will: 1. improve quality of life, physical functioning, coping in everyday-life 2. reduce hospitalization and (re-)admissions for patients with chronic disease, reduce consumption of home care services and can increase consumption of general practice and physiotherapy services in primary health care. 3. improve patient satisfaction and health care providers satisfaction

Chronic Obstructive Pulmonary DiseaseHeart FailureStroke

Norwegian University of Science and Technology54 participantsStarted Sep 2009

Sunndal, Møre Og Romsdal County, Norway • Surnadal, Møre Og Romsdal County, Norway • Klæbu, Sør - Trøndelag, Norway +2 more locations

COMPLETED

The Occurence of Inflammation and Oxidative Stress in Lung Diseases

NCT00512967

Reactive oxygen species (ROS) are suggested to play a pivotal role in ILD. Little is known, however, about the endogenous antioxidant levels in ILD that can offer protection against ROS. It is expected that the high amount of ROS present in ILD will reduce the antioxidant levels. Therefore, antioxidant therapy to strengthen this reduced antioxidant defense might be efficacious in ILD treatment. Since ROS are capable of initiating and mediating inflammation, antioxidant therapy might also mitigate elevated inflammation. A candidate for antioxidant therapy is the flavonoid quercetin that is known for its anti-oxidative and anti-inflammatory capacities. The aim of the present study is to determine the antioxidant and inflammatory status in ILD, i.e. sarcoidosis and idiopathic pulmonary fibrosis (IPF). Furthermore, to evaluate the possible anti-inflammatory effects of antioxidants, the effect of quercetin will be examined on the ex vivo LPS-induced cytokine production in ILD

Interstitial Lung DiseasesSarcoidosisIdiopathic Pulmonary Fibrosis+1 more

Maastricht University Medical Center76 participantsStarted Sep 2005

Maastricht, Netherlands

Well Being and Rehabilitation in Chronically Ill Patients: Structured Patient Education and Physical Exercise

The Occurence of Inflammation and Oxidative Stress in Lung Diseases

Related Searches

Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose Combination

Cholecalciferol Supplementation in Strengthening Inspiratory Muscles in Cholecalciferol-Deficient Patients With Chronic Obstructive Pulmonary Disease

Patient Education in Patients With Chronic Obstructive Pulmonary Disease (COPD) - Effect and Costs

Seasonal Trends in Pneumococcal Carriage in COPD Patients

Comparison of 3-Minute Step Test (3MStepT) and 6-Minute Walk Test (6MWT) in COPD Patients

PT003 MDI Cardiovascular Safety Study

Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD Patients

Tele-spirometry in Primary Care-Randomized Clinical Trial Cluster:Telemedicine in Chronic Obstructive Pulmonary Disease

A Novel Unidirectional Face Mask During NPPV in COPD Patients

Epidemiology and Pulmonary Response To Organic Dust Exposure

Platelet Activation and Reactivity in Acute Exacerbations of COPD

Transdiaphragmatic Pressure and Neural Respiratory Drive Measured During Inspiratory Muscle Training in COPD

Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36)

Efficacy of Aclidinium Bromide Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients

Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD)

Efficacy and Safety of Aclidinium Bromide 400 µg BID (Twice a Day)Compared to Placebo in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Efficacy and Safety of Aclidinium Bromide at Two Dose Levels Versus Placebo Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients

Efficacy and Safety of Aclidinium Bromide 400 µg Compared to Placebo and to Tiotropium Bromide in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)